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Synopsis
PDC (pyruvate dehydrogenase complex) is a multi-enzyme complex comprising an E1 (pyruvate decarboxylase), an E2
(dihydrolipomide acetyltransferase) and an E3 (dihydrolipoamide dehydrogenase). PDC catalyses the decarboxylation
of pyruvate and forms acetyl-CoA and NADH. In the human malaria parasite Plasmodium falciparum, the single
PDC is located exclusively in the apicoplast. Plasmodium PDC is essential for parasite survival in the mosquito
vector and for late liver stage development in the human host, suggesting its suitability as a target for intervention
strategies against malaria. Here, PfaE3 (P. falciparum apicoplast E3) was recombinantly expressed and characterized.
Biochemical parameters were comparable with those determined for E3 from other organisms. A homology model for
PfaE3 reveals an extra anti-parallel β -strand at the position where human E3BP (E3-binding protein) interacts with
E3; a parasite-specific feature that may be exploitable for drug discovery against PDC. To assess the biological role
of Pfae3, it was deleted from P. falciparum and although the mutants are viable, they displayed a highly synchronous
growth phenotype during intra-erythrocytic development. The mutants also showed changes in the expression of some
mitochondrial and antioxidant proteins suggesting that deletion of Pfae3 impacts on the parasite’s metabolic function
with downstream effects on the parasite’s redox homoeostasis and cell cycle.
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INTRODUCTION
The PDC (pyruvate dehydrogenase complex) belongs to the
KADH (α-keto acid dehydrogenases), a family of mega-Dalton
multi-enzyme complexes comprising multiple subunits of three
different enzymes. In mammalian, yeast and nematode PDC, the
E2 (dihydrolipoamide acetyltransferase) together with the E3BP
(E3-binding protein) form the complex core [1–5], whereas in
plants and bacteria it is E2 alone that generates the core of the
PDC complex [6–8]. This core structure forms either a dodeca-
hedral 60-mer, as found in PDC from humans, Gram-positive
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bacteria and plants, or it generates an octahedral 24-mer as is
found in Gram-negative bacteria [7,9–11]. PDC E2 catalyses the
transfer of the acetyl group from S-acetyldihydrolipoamide, a
covalently attached co-factor of E2, to CoA producing acetyl-
CoA. The E1 (pyruvate decarboxylase subunit) of eukaryotes
and Gram-positive bacteria is a heterotetramer composed of two
subunits, E1α (α subunit of E1) and E1β (β subunit of E1),
whereas in Gram-negative bacteria, the enzyme is a homodimer
[12]. PDC E1 transfers the acetyl group from pyruvate to the
thiamine pyrophosphate co-factor, concurrently releasing CO2.
The acetyl moiety is transferred from PDC E1 to the lipoamide
co-factor of E2 which transfers it to CoA to form acetyl-CoA.
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During this reaction the lipoamide co-factor is reduced to DHLA
(dihydrolipoamide) and, in order to allow catalysis to proceed,
E3 (dihydrolipoamide dehydrogenase) re-oxidizes the co-factor,
generating NADH. Both E1 and E3 bind to the E2 core to al-
low substrate channelling, which is facilitated by the so-called
‘swinging arm’, referring to the lipoamide co-factor that is cova-
lently attached to the lipoyl-domains of PDC E2 [13].
In eukaryotes, PDC is located in the mitochondria, linking
cytosolic glycolysis to the mitochondrial TCA (tricarboxylic
acid) cycle; plants possess mitochondrion- and chloroplast-
located PDCs and the plastid-located PDC is vital for providing
acetyl-CoA for fatty acid biosynthesis exclusively occurring in
the organelle [14]. Plasmodium possesses a single PDC that is
found solely in the apicoplast [15], a plastid-like organelle found
in most apicomplexan parasites, where it provides acetyl-CoA for
fatty acid biosynthesis, similar to plant chloroplast PDC [16,17].
It was found that PDC is essential during late liver stage devel-
opment in mouse malaria species [16], whereas in Plasmodium
falciparum, one of the human infective malaria species, recent
studies suggest that PDC and also fatty acid biosynthesis activity
are important for the development of infective sporozoites at the
end of sexual development in the Anopheles vector [18,19]. The
multi-enzyme structure of PDC does however make it probable
that the loss of one protein will not necessarily interfere with the
function(s) of all protein members of the enzyme complex.
Therefore we studied the effects on P. falciparum of the dele-
tion of Pfae3 (Plasmodium falciparum aE3) (PF3D7_0815900),
encoding dihydrolipoamide dehydrogenase, an enzyme that is
an essential component of apicoplast PDC. The enzyme may
also have an impact on parasite’s redox homoeostasis in its own
right. With the aim of informing future anti-malarial drug dis-
covery against exo-erythrocytic parasite stages, Pf aE3 was also
recombinantly expressed and its biochemical and biophysical
characteristics determined.
EXPERIMENTAL
Cloning, recombinant protein expression and
purification of PfaE3
Mature-length Pf aE3 (comprising amino acids 118–667)
was cloned into the vector pQE30 (Qiagen) using ge-
nomic P. falciparum 3D7 DNA as a template and the
forward primer 5′-GCGCGGATCCTTAAAAGGAAGTACAC-
3′ (starting at nucleotide 331 to remove the N-terminal
apicoplast-targeting peptide) and the reverse primer
5′GCGCAAGCTTTTAGTGAGTTCTTATTTTTGATATAG-3′
containing a BamHI and a HindIII restriction site, respectively,
to allow directional cloning into the pQE30 expression vector.
Recombinant mature length Pf aE3 carrying an N-terminal
His-tag was expressed overnight at 30 ◦C in NovaBlue (DE3)
Escherichia coli following induction with 0.5 mM IPTG (iso-
propyl β-D-1-thiogalactopyranoside). Bacteria were harvested
by centrifugation at 3000 g for 15 min at 4 ◦C and the pellets
were resuspended in lysis buffer (50 mM sodium phosphate,
300 mM NaCl, 10 mM imidazole, pH 8.0) containing protease
inhibitors (20 μM leupeptin, 2 μM pepstatin A, 1 mM PMSF,
1 mM benzamidine, 2 μM 1,10-phenanthroline and 10 μM
E-64) and 100 μM flavin adenine dinucleotide. Resuspended
bacterial pellets were incubated on ice for 30 min with 50 μg/ml
lysozyme (Sigma), 1 μg/ml DNase (Roche) before they were
disrupted using a OneShot Cell Disrupter (Constant Systems)
and the lysate was centrifuged at 48 000 g for 1 h. The resulting
supernatant was filtered through a 45 μm Millex-HV PVDF
syringe filter (Millipore) before applying it to Ni-NTA (Ni2 + -
nitrilotriacetic acid) agarose (Qiagen) and incubating for 1 h at
4 ◦C with rotation on a blood wheel. The mix was then poured
into an Econo-Pac chromatography column (Bio-Rad) and the
flow-through was collected by gravity flow. The Ni-NTA resin
was washed twice with 4 volumes of wash buffer 1 (50 mM
sodium phosphate, 300 mM NaCl, 20 mM imidazole, pH 8.0)
and subsequently with 1 volume wash buffer 2 (50 mM sodium
phosphate, 300 mM NaCl, 50 mM imidazole, pH 8.0), before the
recombinant protein was eluted with 50 mM sodium phosphate,
300 mM NaCl, 250 mM imidazole, pH 8.0. Protein purity was
assessed by SDS–PAGE (10 % gel). Fractions containing the
recombinant protein were pooled and applied to a previously
calibrated HiLoad 16/60 Superdex 200 chromatography column
for further purification. The column was equilibrated with
50 mM potassium phosphate, 150 mM NaCl, 2 mM EDTA,
pH 7.4. The calibration standards used were dextran blue
(2 MDa, 0.6 mg/ml), apoferritin (440 kDa, 2.5 mg/ml), alcohol
dehydrogenase (150 kDa, 2.5 mg/ml), bovine serum albumin
(66 kDa, 2.5 mg/ml), carbonic anhydrase (29 kDa, 2.5 mg/ml)
and cytochrome c (12 kDa, 2.5 mg/ml). The elution fractions
containing Pf aE3 were analysed by SDS–PAGE (10 %) and
Western blotting.
Activity assays
The catalytic activity of Pf aE3 was assessed as described
by McMillan et al. [20]. The generation or consumption of
NADH was determined spectrophotometrically by measuring
the change in absorbance at 340 nm in a UV-2501 spectrophoto-
meter (Shimadzu). The extinction coefficient of NADH at 340 nm
(6220/M/cm) was used to calculate the specific activity of re-
combinant Pf aE3 in the forward and reverse reactions. One unit
of Pf aE3 in the forward reaction activity is defined as 1 μmol
of NAD+ reduced per min per mg of enzyme, while 1 unit of
Pf aE3 activity in the reverse reaction is defined as 1 μmol of
NADH oxidized per min per mg enzyme. The forward reaction
was performed in 50 mM potassium phosphate, 1 mM EDTA,
pH 8 with 1 μg of recombinant Pf aE3 at 25 ◦C. A 60 mM stock
of DHLA (Sigma) was freshly prepared in 100 % (v/v) ethanol
and 10 mM NAD+ was freshly prepared with reaction buffer.
The Km and vmax values for DHLA were determined by keep-
ing NAD+ constant at 2 mM and varying the concentration of
DHLA (50 μM–2 mM). The kinetic parameters for NAD+ were
determined, keeping the DHLA concentration constant at 2 mM
and varying the NAD+ concentration (62.5 μM and 2 mM). The
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reverse reaction was performed in 50 mM potassium phosphate,
1 mM EDTA, pH 7, at 25 ◦C with 1 μg of Pf aE3. Lipoamide
(Sigma) was freshly prepared with 100 % ethanol as a 60 mM
stock solution. NADH was prepared in reaction buffer as a 10 mM
stock solution. To determine the Km and vmax values for lipoam-
ide, the concentration of NADH was kept constant at 200 μM and
lipoamide was varied between 50 μM and 4 mM. For the kinetic
parameters for NADH, lipoamide was kept constant at 2 mM and
NADH was varied between 10 and 200 μM.
Analytical ultracentrifugation (AUC)
AUC analysis was performed using a Beckman Coulter Op-
tima XL-I analytical ultracentrifuge (Palo Alto). SV (sediment-
ation velocity) experiments were carried out at 49 000 rpm at
4 ◦C. Equal (360 μl) volumes of protein (ranging from 3.1 to
22.7 μM) and reference solvent (50 mM potassium phosphate,
250 mM NaCl, 2 mM EDTA, pH 7.4) were loaded into 12 mm
charcoal-filled epon double sector centerpieces. Concentration
distributions (200) were recorded every 2 min using absorbance
optics. The program SEDFIT [21,22] was then used to model the
SV profiles with finite-element solutions of the Lamm equation
for a large number of discrete, non-interacting species result-
ing in a continuous size distribution [c(s) versus s]. Initial fits
were conducted over the range of 0.0–25 S to cover all plausible
species. High-resolution (resolution = 200) fits were then per-
formed within a narrower range (0–15 S, which transformed to
0.0–26.1 S when standardized to the 20 ◦C, water scale). Using
SEDNTERP [23] (http://sednterp.unh.edu/) the partial specific
volume of Pf aE3 (0.732 ml/g at 4 ◦C and 0.739 ml/g at 20 ◦C)
and the reference buffer density and viscosity (ρ = 1.01 804 g/ml
and η = 1.6354 cPoise, respectively, at 4 ◦C) were computed.
The sedimentation coefficients obtained by integration of the
c(s) peaks were plotted against protein concentration to obtain
the sedimentation coefficient at infinite dilution (s020,w ) from the
y-intercept.
SE (sedimentation equilibrium) experiments were carried out
at 17 000 rpm at 4 ◦C. Equal volumes (80 μl) of Pf aE3 at con-
centrations ranging from 4.7 to 22.7 μM and reference buffer
(50 mM potassium phosphate, 250 mM NaCl, 2 mM EDTA,
pH 7.4) were loaded into double sector 12 mm path length
centrepieces. As interference optics were used to record data,
the laser delay, fringe contrast and brightness at the exper-
imental speed were adjusted before the run to obtain high-
quality fringes. Ten scans were recorded over a radial range
of 6.80–7.25 cm and were taken 3 h apart following a 3 h
initial delay. WinMATCH (Jeffrey Lary, University of Con-
necticut, Storrs, CT, USA) was used to confirm that equilib-
rium had been reached in the sample. SE data were fit us-
ing the species analysis model in SEDPHAT [24,25] (http://
www.analyticalultracentrifugation.com/sedphat/sedphat.htm).
Small-angle X-ray scattering
SAXS (small-angle X-ray scattering) data were acquired on the
EMBL beamline X33 at DESY, Hamburg. The beam current
was 100–140 mA and the X-ray wavelength was 1.5 ˚A. The
sample to detector distance was 2.7 m giving a momentum
transfer (s = 4π sin (θ )/λ, where 2θ is the scattering angle
and λ is the X-ray wavelength) range of 0.006s0.6 ˚A− 1.
Data were collected with a 2D photon counting Pilatus 1M-
W pixel X-ray detector, which was calibrated with a standard
sample of 5 mg/ml bovine serum albumin. Pf aE3 was purified
two days before measurements and homogeneity was determ-
ined by SV analysis before and after measurements. Protein
activity was also confirmed on the day of purification. SAXS
data were acquired at 10 ◦C for Pf aE3 at concentrations of 9,
8, 6, 5 and 4 μM. The exposure time of the sample to the X-
rays was 15 s and eight frames were taken for each sample. The
raw data were processed with an automated SAXS data pro-
cessing pipeline [26] for initial averaging of sample data frames
and buffer subtractions. The ATSAS 2.5 programme suite [27]
(http://www.embl-hamburg.de/biosaxs/software.html) was used
for all subsequent processing and analysis of SAXS data, apart
from Sc ˚Atter (http://www.bioisis.net/tutorial/9) which was used
to generate dimensionless Kratky plots. PRIMUS [28] was used
to assess the data for aggregation and to perform Guinier ana-
lysis. High-angle data for the 9 μM protein and low-angle data
for the 4 μM protein were merged and the resulting scattering
curve was used for all subsequent analyses, including determin-
ation of the p(r) distance distribution function and the maximum
dimension (Dmax) using GNOM [29]. Rg was determined both
from the Guinier approximation and the p(r) distribution.
Structural modelling
Ab initio modelling of the solution conformation of Pf aE3
from the SAXS data using P2 symmetry was carried
out using DAMMIF [30] on the ATSAS online server
(http://www.embl-hamburg.de/biosaxs/atsas-online/dammif.php)
[26]. An atomic resolution model for a monomer of Pf aE3 was
constructed from a combination of models generated using the
PHYRE2 server [31] and the I-TASSER server [32]. This was
then superimposed on one chain of the dimer structure of human
E3 (PDB ID: 2F5Z, [33]) using PyMol (Schro¨dinger, LLC)
and the process repeated for the second chain of human E3 in
order to gain an overview of how a putative Pf aE3 dimer would
compare with its human counterpart.
P. falciparum culture
P. falciparum 3D7 (The Netherlands) was cultured according to
Trager and Jensen [34] in RPMI 1640 (Invitrogen) containing
11 mM glucose, 0.5 % (w/v) Albumax II (Invitrogen), 200 μM
hypoxanthine, 20 μg/ml gentamycin (PAA) in human erythro-
cytes between 0.5 and 5 % (w/v) haematocrit. Parasite cultures
were maintained under an atmosphere of reduced oxygen [1 %
(v/v) oxygen, 3 % (v/v) CO2 and 96 % (v/v) nitrogen]. Parasites
were synchronized using sorbitol [35] and freed from erythro-
cytes using saponin [36]. Parasitaemia was determined using
Giemsa-stained thin smears.
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Generation of Pfae3 knockout construct and
transfection of P. falciparum
The 5′ and 3′ ends of Pfae3 were cloned into pCC1 [37] flanking
the hdhfr (human dihydrofolate reductase) selectable marker cas-
sette. The primers used to amplify the 5′ fragment [nucleotides
37–526 of the ae3 ORF (open reading frame)] were ae3-5′s: 5′-
GAGCACTAGTCTTAACGTCGTTACTCTAATTTGGTATC-3′
and ae3-5′as: 5′-GAGCCTTAAGGCGCTTTGCTTGG-
TATACAGCC-3′ containing an SpeI and AflII restriction
site, respectively. The primers used to amplify the 3′ frag-
ment (nucleotides 1456–2001 of the ae3 ORF) were ae3-
3′s: 5′-GAGCGAATTCGCACACACAGCATCATATCAAG-3′
and ae3-3′as: 5′-GAGCCCTAGGTTAGTGAGTTCTTATTT-
TTGATATAGA-3′ containing an EcoRI and AvrII restriction
site, respectively. The nucleotide sequence of pCC1-	Pfae3
was verified (Eurofins MWG Operon).
Transfection of pCC1-	Pfae3 P. falciparum 3D7 erythrocytic
stages was performed as described previously [38]. Transfectants
were selected with 2.5 nM WR99210. Before cloning by limiting
dilution according to Kirkman et al. [39], pCC1-	Pfae3 trans-
fectants were subjected to negative selection with 1 μM 5-FC.
DNA and protein extraction
Parasites were freed from erythrocytes using saponin lysis and
genomic DNA was isolated by resuspending the washed pellet
in 50 mM Tris–HCl, pH 9 containing 0.2 M NaCl, 0.1 M EDTA,
1 mg/ml proteinase K and 1 % (w/v) SDS and incubated overnight
at 37 ◦C with rotation. This was followed by phenol extraction
and the genomic DNA was precipitated with isopropanol. After
washing the genomic DNA with 70 % ethanol it was dissolved in
200 μl of Tris–HCl, pH 8.0 containing 1 mM EDTA.
For protein extraction the parasite pellet was resuspended in
2D-lysis buffer (100 mM Hepes pH 7.4, 5 mM MgCl2, 10 mM
EDTA, 0.5 % (v/v) Triton X-100, 5 μg/ml RNase A, 1 mM
PMSF, 1 mM benzamidine, 2 μg/ml leupeptin, 10 μM E-64,
2 mM 1,10- phenanthroline, 4 μM pepstatin A). The parasite
pellet was freeze-thawed three times in dry ice and sonicated
for 5 min in a sonicating water bath at 4 ◦C. Subsequently the
samples were centrifuged at 13 000 g at 4 ◦C for 15 min and the
protein concentration of the supernatant was determined using
the Bradford method with bovine serum albumin as a standard
[40].
Western blotting
Separation of proteins (20 μg) was performed by SDS–PAGE
using NuPage Novex 4–12 % and 10 % (w/v) bis-Tris gels (In-
vitrogen). Proteins were either stained with Coomassie Brilliant
Blue or were transferred to Protran nitrocellulose membranes
(Schleicher & Schuell) using a Transblot semi-dry transfer sys-
tem (BioRad). Western blots were blocked in 5 % (w/v) non-fat
dried skimmed milk dissolved in PBS overnight at 4 ◦C before
the primary antibodies were applied for 1 h at room temperature.
For protein identification, a mouse anti-His-tag antibody (BD
Biosciences) was used at 1:25 000 dilution; after three washes
the membranes were then incubated with HRP (horseradish per-
oxidase) conjugated secondary antibody (1:10 000, anti-mouse-
HRP; Promega) for 1 h at room temperature before the blot was
washed three times and developed using the Immobilon West-
ern Chemiluminescent substrate (Millipore) following manufac-
turer’s instructions. The signals were visualized by exposing the
blots to X-ray films.
For relative quantification analyses, the blots were probed
simultaneously with P. falciparum rabbit anti-actin antibody
(1:12 000, used as loading control) and one antibody of in-
terest (P. falciparum rabbit anti-branched chain α-keto acid de-
hydrogenase E2 antibody at 1:5000; P. falciparum rabbit anti-
isocitrate dehydrogenase antibody at 1:10 000; P. falciparum
rabbit anti-mitochondrial E3 antibody at 1:2500; P. falciparum
rabbit anti-malate dehydrogenase at 1:2000; P. falciparum rab-
bit anti-glutathione reductase antibody at 1:2500; P. falciparum
rabbit anti-GST (glutathione S-transferase) antibody at 1:2500;
P. falciparum rabbit anti-1-CysPx (1-Cys peroxiredoxin) anti-
body 1:50 000; P. falciparum rabbit anti-2-CysPx (2-Cys perox-
iredoxin) antibody at 1:70 000; P. falciparum rabbit anti-PDC –
E2 lipoyl – domain antibody at 1:250). The membranes were then
washed three times in PBS and probed for 1 h at room temperat-
ure with an IR dye-conjugated antibody (1:10 000, IRDye 800CW
goat anti-rabbit antibody; LI-COR biosciences). After three PBS
washes the fluorescent signals were acquired with the Odyssey
SA scanner (LI-COR biosciences) and band intensities quantified
with the provided software.
Southern blotting
Two to 3 μg of genomic DNA and 0.2 ng of the pCC1-	Pfae3
plasmid were digested at 37 ◦C overnight with HincII. The diges-
ted DNA was separated on a 0.8 % (w/v) agarose gel and sub-
sequently blotted onto Hybond N+ membranes. The membranes
were probed with the PfaE3 5′ fragment cloned into pCC1 (nuc-
leotides 37–526 of the ae3 ORF), which was labelled using the
Gene Images AlkPhos Direct Labelling kit (GE Healthcare) ac-
cording to the manufacturer’s recommendations. The membranes
were probed overnight at 60 ◦C and then washed as recommen-
ded by the manufacturer. Visualization of DNA fragments on the
membranes was achieved using CDP Star detection solution (GE
Healthcare) followed by exposure of the membrane to autoradio-
graphy film.
Growth assay
3D7	Pfae3 growth was determined as described by Gu¨nther
et al. [41] with modifications. Cultures were synchronized twice
during 4 h. The ring stage parasites were diluted to 0.5 % parasit-
aemia and 5 % haematocrit in 2 ml of RPMI complete medium.
Each parasite line was analysed in triplicate. Giemsa stained
thin smears were prepared daily and the cultures were diluted
1:5 with fresh erythrocytes every second day. The parasitaemia
was determined by counting 1000 erythrocytes. In addition,
the development of the erythrocytic stages was monitored by
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counting 100 parasites per slide distinguishing rings, trophozo-
ites and schizonts.
Determination of IC50 values
The incorporation of [3H]-hypoxanthine was used to determine
IC50 values [42] for BSO (L-buthionine sulfoximine), paraquat
and triclosan. The starting concentrations for the agents were
1.25 mM for BSO, 0.5 mM for paraquat and 0.4 mM for tricolsan.
Following incubation for 48 h, the medium (without further addi-
tion of drugs) was replaced and 5 μCi [3H]-hypoxanthine per ml
was added to each well. The plates were incubated for a further
24 h after which they were frozen at − 20 ◦C. The plates were
defrosted at room temperature for 2–3 h before harvesting with a
Harvester 96TM Mach III (TomTec) onto Printed Filter Mat A fil-
ter mats (Perkin Elmer). These were dried at 55 ◦C for 90 min and
sealed into plastic sample bags after addition of 4 ml of scintil-
lation fluid and determining incorporation of [3H]-hypoxanthine
using a Wallac 1450 MicroBeta Trilux liquid scintillation counter
(Perkin Elmer) for 1 min per well. IC50 values were calculated
using GraphPad Prism 5.0.
RESULTS
Recombinant expression, purification and catalytic
parameters of PfaE3
P. falciparum aE3 (Pf aE3) was recombinantly expressed in E.
coli using an N-terminally truncated construct (amino acids 110–
667) containing an N-terminal 6-His-tag. The protein was purified
in a two-step process using Ni-NTA agarose batch purification
followed by gel filtration on Superdex S200. The presence of
the His-tagged protein (∼64 kDa after Ni-NTA chromatography)
was verified by Western blotting where substantive degradation
of the recombinant protein was detected (Figure 1). Gel filtration
resulted in the separation of the applied proteins into two major
peaks (peaks 1 and 2) corresponding to proteins of ∼140 and
∼35 kDa (Figures 1C and 1D). SDS–PAGE revealed that peak
1 contained two polypeptides of approximately 60–64 kDa (Fig-
ure 1E). Both were His-tagged, as verified by Western blotting
(Figure 1F) and presumably corresponded to full-length and a
C-terminally truncated form of Pf aE3. As opposed to the pre-
vious expression trial reported by McMillan et al. [20], which
obtained only marginal amounts of recombinant Pf aE3, the yield
of recombinant Pf aE3 using the pQE30 expression plasmid was
1.5 mg/l of bacterial culture, which allowed for kinetic and struc-
tural analyses of the recombinant protein.
Pf aE3 was found to be catalytically active in both forward
and reverse reactions (Table 1). In the forward reaction, the Km
for DHLA was about 10-fold higher than that of P. falciparum
mE3 and the protozoan parasite Trypanosoma cruzi E3 [43] and
compares well with the value for human E3 [20,43,44]. This
is as opposed to the Km determined for NAD+ , which is five
times lower than that of the E3s from other organisms. However,
the turnover numbers of Pf aE3 for both substrates in the forward
reaction are similar to those determined for E3 from other species,
suggesting that at substrate saturation PfaE3 is as catalytically
competent as the mE3 (mitochondrial E3) proteins. This is not
the same for the reverse reaction, where the kcat for both NADH
and lipoamide are well below those determined for Pf mE3 but
compare favourably with the kinetic parameters determined for
the T. cruzi protein [43].
PfaE3 is a dimer
In common with E3 from other organisms, Pf aE3 elutes in size
exclusion chromatography as a homo-dimer of ∼140 kDa (Fig-
ures 1C and 1D). This observation was verified by AUC. SV
showed a main species (Figure 2A) with a sedimentation coef-
ficient s020,w of 6.2 +− 0.1 S (Figure 2B), comparable with that
determined for the human E3 dimer (5.9 S, [45]) suggesting that
the overall solution conformation and oligomerization state might
be similar.
To determine the molecular mass of Pf aE3, SE analysis was
undertaken. The data were fitted with a single species model (Fig-
ure 2C) and the resultant weight average molecular masses were
plotted as a function of Pf aE3 dimer concentration (Figure 2D)
yielding an infinite dilution whole-cell weight average molecu-
lar mass of 128 kDa, remarkably close to the molecular mass of
the Pf aE3 dimer calculated from the amino acid sequence of the
recombinantly expressed full-length protein (127 478 kDa) (see
above).
SAXS data (Figure 3A) were acquired on the EMBL beamline
X33 at DESY, Hamburg. One day before SAXS, the homogen-
eity [a single 6.3 S species (results not shown)] of the Pf aE3 was
confirmed by SV. Two days after SAXS, some of the proteins
had degraded resulting in a small amount (5 %) of a 3.9 S spe-
cies in addition to the main 6.3 S species. Protein activity was
also confirmed on the day of purification. A maximum at an sRg
just above √3 in the dimensionless Kratky plot (s R2g I (s)/I (0)
versus sRg) of the SAXS data demonstrated that the protein was
folded and elongated and the linear Guinier region in the data
at low angles confirmed that there was no aggregation in the
sample (results not shown). The radius of gyration, Rg, determ-
ined from the Guinier analysis was 37.6 +− 0.3 ˚A. GNOM [29]
was used to determine the distance distribution function, p(r),
from which the maximum dimension of the particle, Dmax, was
determined (129 ˚A). The Rg estimated from GNOM analysis,
37.5 +− 0.04 ˚A, was similar to that determined from the Guinier
region. The bell shape of the p(r) curve (results not shown) has
a short tail, indicative of a globular particle which is slightly
elongated, in agreement with the dimensionless Kratky analysis.
Twenty ab initio DAMs (dummy atom models) generated using
the program DAMMIF [30] were clustered by DAMCLUST [27]
into three groups, cluster 1 (comprising eight models), cluster 2
(comprising five models) and cluster 3 (comprising seven mod-
els). The sedimentation coefficient of the representative model
of each group was computed using US-SOMO [46,47]. Best
agreement was obtained for cluster 2 for which s020,w was 6.43 S
(whereas it was 6.88 and 6.83 S for clusters 1 and 3, respectively)
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Figure 1 Purification of recombinant PfaE3
(A) SDS–PAGE (10 % gel) of recombinant PfaE3 after Ni2 + -NTA batch purification. Roughly 30–50 μg of protein were
loaded per lane (lane L is the bacterial lysate applied to the resin and lane 1 of the wash fractions -- 50 μg each; lanes
2 and 3 of the wash fractions and lanes 1 and 2 of the elution fractions -- 30 μg each) and proteins were visualized
with Coomassie Brilliant Blue. A protein of about 64 kDa (arrow) was enriched. (B) The enriched protein (arrow) was
His-tagged as verified by Western blotting using an anti-His-tag antibody. Other lower molecular mass proteins also reacted
with the antibodies; these are presumably degradation products. (C) The elution fractions 1 and 2 from the Ni2 + -NTA
batch purification containing PfaE3 were applied to a HiLoad 16/60 Superdex S200 column previously calibrated with
dextran blue (2000 kDa, void volume), apoferritin (440 kDa), β-amylase (200 kDa), alcohol dehydrogenase (150 kDa), BSA
(66 kDa), carbonic anhydrase (29 kDa) and cytochrome c (12 kDa). The figure shows the elution profile featuring two major
protein peaks (1 and 2). A third peak eluting at about 45 ml corresponds to the void volume of the column (void) and may
be attributable to protein aggregates forming during the purification procedure. (D) Calibration curve of Superdex S200
column. Interpolation of the ve/v0 of PfaE3 peak 1 with the calibration curve of the Superdex S200 column suggests that
this protein has a molecular mass of about 140 kDa. Peak 2 represents a protein much smaller than PfaE3 (∼35 kDa). (E)
SDS–PAGE (10 % gel) shows that peak 1 from the gel filtration contained two closely migrating proteins of approximately
60–64 kDa (arrows). Peak 2 does not contain proteins of the expected size of PfaE3. P, pooled Ni2 + -NTA elutions applied
to Superdex S200; V, protein eluted at void volume; 1 and 2, proteins eluted in peaks 1 and 2, respectively. (F) The protein
present in peak 1 was confirmed to be PfaE3 by western blotting with anti-His-tag antibody (arrows).
in good agreement with the experimentally determined value
(6.2 S).
An atomic resolution model of Pf aE3 was generated using the
PHYRE2 server [31]. Coordinates were generated for 514 of the
566 residues: the first 12 residues (including the His-tag) were
not modelled, and the final residue (also a histidine) was absent.
In addition, two longer sequences [of 19 and 20 amino acids
(residues 96–114 and 465–484), respectively] were not modelled.
They have no structural homologues in the Protein Data Bank
[48]. An additional model was generated with the I-TASSER
server [32] in which all the residues were modelled. Dimer forms
of both models were generated by superimposition on the dimer
structure of human E3 (PDB ID: 2F5Z, [33]). Whilst the PHYRE2
monomer superimposed well, residues 406–420 of the I-TASSER
monomers sterically clashed. Therefore a composite model was
made in which residues 403–418 of the I-TASSER model were
replaced with those from the PHYRE2 model. This composite
dimer was then superimposed on the human E3 dimer structure
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Table 1 Kinetic parameters of PfaE3
Forward and reverse reactions were followed and catalytic parameters determined as outlined in the Experimental
Procedures. PfaE3 values represent means +− S.E.M. of three independent measurements.
PfaE3 PfmE3 [20] Homo sapiens E3 [44] Trypanosoma cruzi E3 [43]
Forward
Km DHLA (μM) 1160 +− 105 146 +− 15 570 130
kcat DHLA (s− 1) 110 135 382 166 (pH 7.0) [20]
244 (pH 7.5)*
Km NAD+ (μM) 96 +− 12 450 +− 30 290 600
kcat NAD+ (s− 1) 110 135 to 337 382 166 (pH 7.0) [20]
244 (pH 7.5)*
Reverse
Km lipoamide (μM) 841 +− 97 870 +− 270 1010 800
kcat lipoamide (s− 1) 97 448 167 106 (pH 7.0) [20]
91 (pH 7.5) [20]
Km NADH (μM) 15 +− 2 21 +− 6 51 25
kcat NADH (s− 1) 77.8 448 167 106 (pH 7.0) [20]
91 (pH 7.5) [20]
*Recalculated from the indicated reference assuming a molecular mass of 50 kDa for T. cruzi E3.
without steric clashes. US-SOMO [46,47] was used to compute
s020,w and Rg for this dimer, giving 7.13 S and 31.6 ˚A, respectively,
in poor agreement with the experimentally determined values of
6.2 S and 37.5 ˚A.
Anticipating that the disagreement between calculated and
experimental values might originate from flexibility in extended
surface loops observed in the Pf aE3 model but not the human
structure, 5000 ‘fleximers’ of these loops (residues 88–123 and
406–420) and the first 27 residues (including the His-tag) were
generated using the DMD (discrete molecular dynamics; [49,50])
tool in US-SOMO with an Andersen thermostat temperature of
0.5 kcal/mol/kB, where most proteins will not unfold or deviate
much from native state (Figure 3C). GAJOE [51] was then used
to select an ensemble of fleximers whose combined theoretical
scattering intensity gives best agreement with the experimental
SAXS data. A representative model is shown in Figure 3(D) for
which s020,w and Rg were computed (using US-SOMO) to be
6.30 S and 33.5 ˚A, respectively, in better agreement with the
experimental data than the initial dimer model. The Pf aE3 dimer
model incorporates an extra anti-parallel β-strand in the space
that would, in the complex of human E3 and E3BP, be occupied
by the SBD (sub-unit binding domain) of E3BP (Figure 3B).
The dimer model was also superimposed (using SUPCOMB
[52]) on the representative cluster 2 DAM. The overlay highlights
a key difference between the two models: the DAM was gener-
ated with P2 symmetry constraints, whereas the fleximers were
generated from an initially symmetrical dimer in the absence of
symmetrical constraints. This observation notwithstanding, the
majority of the two models overlay reasonably well (Figure 3D),
acknowledging that this model is only one of an ensemble that
agrees with experimental data and it is not unreasonable to en-
visage a slightly different conformer overlaying well with other
parts of the DAM not occupied by this model. Thus the SAXS
data confirm the dimeric nature of Pf aE3 and are consistent with
a model in which parasite-specific regions of the protein extend
from the globular core.
Physiological role of PfaE3
The physiological role of Pf aE3 was probed by deleting ae3 in P.
falciparum 3D7 (Figure 4). The gene was replaced by the select-
able marker hdhfr after initial positive selection with WR99210
followed by negative selection using 5-FC (5-fluorocytosine)
generating the line 3D7	ae3 (Figure 4B). Several clones were isol-
ated (Figure 4C) and clones 16, 21 and 34 were investigated fur-
ther. The mutant parasite clones did not show an obvious growth
phenotype, although it was noted that they grew extremely syn-
chronous – even after three growth cycles they maintained their
synchronicity (Figure 5). These data corroborate that Pf aE3 is not
essential for parasite survival during intra-erythrocytic growth
although their tendency to maintain synchronous growth sug-
gests that the gene deletion affects progression through their cell
cycle. Whether this is exerted by affecting the number of merozo-
ites generated per cell or synchronicity of mitotic activity itself or
whether it is caused by affecting re-invasion of fresh erythrocytes
by daughter merozoites has to be established in future work.
Given the potential role of Pf aE3 producing NADH for down-
stream reductive reactions that may be important for the antiox-
idant defence of the apicoplast and possibly other compartments
of the parasite cell, the susceptibility of inhibitors increasing
oxidative stress was determined (Table 2). Reduction of gluta-
thione levels by BSO, a specific inhibitor of γ -glutamylcysteine
synthetase [53] had a differential effect on the survival of the
parasites, with clones 16 and 34 being more sensitive to inhibi-
tion with BSO than clone 21 and wild-type 3D7 (Table 2). This
differential effect was even more pronounced when the suscept-
ibility towards paraquat, a known pro-oxidant [54–56] was de-
termined. The 3D7	ae3 clones 16 and 34 showed decreased IC50
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Figure 2 AUC analyses of PfaE3
(A) Size distribution [c(s) versus s] analysis of AUC SV data with SEDFIT [21,22] was carried out for PfaE3 at dimer
concentrations from 3.1 to 22.7 μM. The main species accounted for 68–94 % of the sample. Inset shows a ‘zoom’
into the analysis over the range 1.0s20,w10.0 S. (B) Concentration dependence of s20,w from which the sedimentation
coefficient at infinite dilution (s020,w = 6.2 +− 0.1 S) was determined. The error bars represent the standard deviation shown
as the square root of the central moment of the curve. (C) SE interference data (for clarity, only every 4th data point is
shown for each concentration) were analysed with SEDPHAT [25] using a single species model for which the fit is shown
(smooth line). Residuals of the individual fits are shown beneath the fitted data. (D) The molecular mass resulting from
the fits in (C) are plotted as a function of PfaE3 dimer concentration. At infinite dilution the molecular mass is 128 kDa.
Plots in panels (A) and (C) were prepared using the program GUSSI (http://biophysics.swmed.edu/MBR/software.html).
values (one-third of the IC50 value determined for wild-type 3D7),
whereas this was not the case for 3D7	ae3 clone 21. These data
imply that the deletion of ae3 results in a differential adapta-
tion of parasites to the gene removal. Triclosan, an inhibitor of
FabI (an enoyl-acyl carrier reductase) and a component of fatty
acid biosynthesis [57–59], shows differential inhibition of the
mutant clones, which appears to be opposite of that found by
pro-oxidants.
These data prompted us to further assess the physiological
state of 3D7	ae3 clones and we analysed potential changes
in protein levels involved in the maintenance of the intracel-
lular cytoplasmic redox state (Figure 6). Cytosolic 1-CysPx,
PF3D7_0802200) and 2-CysPx, PF3D7_1438900) as well as
GST (PF3D7_1419300) were marginally up-regulated in 3D7	ae3
clone 21, suggesting that deletion of Pfae3 triggers an up-
regulation of parasite’s antioxidant response (Figure 6A). How-
ever, this was not observed in 3D7	ae3 clones 16 and 34, where
levels of both peroxiredoxins were lowered and GST was not or
only marginally affected (Figure 6B).
The levels of mitochondrial proteins such as branched chain
α-keto acid dehydrogenase E2 (BCDH-E2; PF3D7_0303700)
were elevated in all mutant parasite clones although this par-
ticularly pronounced in clone 21. This tendency correlated well
with increased levels of mitochondrial NADP+ -dependent ICDH
(isocitrate dehydrogenase; PF3D7_1345700) as well as slightly
elevated levels of mE3 (PF3D7_1232200) in 3D7PfΔae3clones 16
and 34 (Figure 6B).
The PDC–E2 protein level was unaffected in 3D7PfΔae3clones
16 and 34 suggesting that this component of PDC is still expressed
at normal levels in mutant parasites.
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Figure 3 Modelling of PfaE3
(A) SAXS data (open circles) with fits by (blue line, ϕ = 0.823) the DAM shown in (D); (orange line, ϕ = 0.787) the
representative fleximer model after DMD optimization [in blue, green and orange in (D)]. (B) An atomic resolution model
for a dimer of PfaE3 constructed from a combination of models generated using the PHYRE2 server [31] and the I-TASSER
server [32] superimposed on the dimer structure of human E3 (PDB ID: 2F5Z, [33]). The PfaE3 dimer model incorporates
an extra anti-parallel β strand in the space that would, in the complex of human E3 and E3BP, be occupied by the E3BP
subunit-binding domain (indicated for one chain by a red-dashed ellipse). (C) Seven fleximers overlaid to illustrate the
scope of conformational space explored by the models generated by the DMD process. Three regions were allowed to flex
during the modelling: residues 1–27, 88–123 and 406–420. Key: model 1 (red); model 1000 (orange); model 2000 (light
green); model 3000 (dark green); representative fleximer (model 3242, blue); model 4000 (purple); model 5000 (pink).
(D) The representative fleximer model superimposed on the cluster 2 DAM.
DISCUSSION
Plasmodium possesses a single PDC exclusively found in the api-
coplast [15]. The three other KADH complexes are mitochondrial
[60] and this distribution requires the presence of apicoplast- and
mitochondrion-specific dihydrolipoaminde dehydrogenases (E3)
that interact with their organelle-specific KADH [20,61]. In ac-
cordance with this distribution, mitochondrial KADH complexes
share a single E3 (mE3; PF3D7_1232200), while the apicoplast
PDC has its own, apicoplast-located E3 encoded by a separate
gene (aE3; PF3D7_0815900) [20]. Experimental evidence sug-
gests that apicoplast-located PDC is not essential for the survival
of intra-erythrocytic Plasmodium yoelii [16] but that the protein
is important for late liver stage development. Recently the gene
encoding PDC E1α was also deleted in the human malaria spe-
cies P. falciparum resulting in the arrest of parasite development
at the oocyst stage in the Anopheles vector [18]. Similar results
were obtained when genes encoding components of the type II
fatty acid biosynthesis pathway were deleted from P. falciparum,
supporting the hypothesis that, as in plants, the major role of
apicoplast PDC is to provide acetyl-CoA for this biosynthetic
pathway [16,19,62].
The potential suitability of PDC as a target for transmission
blocking or exo-erythrocytic drug discovery prompted us to re-
combinantly express PfaE3 and analyse its biochemical proper-
ties. Kinetically Pf aE3 favours the forward reaction (the oxida-
tion of DHLA and reduction of NAD+ ), rather than the reverse
reaction (Table 1). This suggests that in its physiological envir-
onment the enzyme is primarily acting as part of apicoplast PDC
rather than undergoing redox reactions to assist in maintaining
organellar redox and antioxidant homoeostasis, as has been
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Figure 4 Knockout of the Pfae3 gene
(A) A schematic representation (not to scale) of the expected DNA fragment sizes using the 5′ flank of the transfection
plasmid (star) following digestion of genomic DNA with HincII. (I) Digestion of the endogenous gene results in a 2.7 kb
fragment; (II) digestion of the transfected plasmid pCC1-	PfaE3 results in a 7.8 kb fragment; (III) following integration of
the pCC1-	PfaE3 plasmid, digestion of the ae3 locus with HincII results in a 3.9 kb fragment. (B) Southern blot of genomic
DNA (2.5 μg) of 3D7 wild-type (WT 3D7), the transfected line Pf3D7	PfaE3 and the transfected plasmid pCC1-	PfaE3 after
digestion with HincII showed a DNA fragment of 2.7 kb in the 3D7 wild-type genomic DNA diagnostic for the ae3 gene
locus. In the genomic DNA of the transfected parasite line a band diagnostic for the gene deletion (3.9 kb) was detectable
and in the lane where the plasmid was loaded, the expected 7.8 kb DNA fragment was detected. (C) Southern blot of
genomic DNA of P. falciparum 3D7 wild-type and five clones (2.5 μg; clones numbered 16, 21, 25, 32 and 34) was digested
with HincII and probed as described in (B). This confirmed the deletion of the Pfae3 gene, as only the 3.9 kb integration
fragment was detected, in the clonal parasite lines.
Figure 5 Growth of 3D7 and 3D7PfaE3
Synchronized 3D7 and 3D7	PfaE3 clones 16, 21 and 34 were diluted to approximately 0.5 % parasitaemia at day 0. The
cultures were diluted 1:5 with fresh erythrocytes every 2 days and parasitaemia (A) and parasite stage (B) were determined
in Giemsa stained thin smears over three growth cycles. Data shown represent means of two independent experiments
performed in triplicate +− S.D. Abbreviations: WT: 3D7 wild-type; KO: 3D7	Pfae3 clones 16, 21 and 34.
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Table 2 Sensitivity to inhibitors
The data represent means from two to three independent determinations +−S.D. performed in triplicate.
Inhibitor IC50 3D7 (μM) IC503D7Pfae3 clone 16 (μM) IC503D7Pfae3 clone 21 (μM) IC503D7ΔPfae3 clone 34 (μM)
BSO 32.2 +− 1.0 21.1 +− 1.0 40.4 +− 2.5 21.9 +− 2.0
Paraquat 34.8 +− 4.0 12.0 +− 1.7 37.7 +− 3.1 14.9 +− 1.9
Triclosan 6.2 +− 1.2 13.8 +− 1.7 2.4 +− 0.3 14.3 +− 2.2
suggested for other organisms [63,64]. The structural stability
of Pf aE3 was probed by AUC. The whole cell weight average
molecular mass at infinite dilution of Pf aE3 determined by SE
was consistent with that expected for a dimeric species. However
during SDS–PAGE PfaE3 migrates as two species, both of which
are N-terminally 6-His tagged suggesting that the faster migrat-
ing protein may have lost parts of its C-terminus. Deletion of the
C-terminal 14 amino acids of Azotobacter vinelandii E3 led to its
inactivation, decreased its thermostability and also negatively af-
fected FAD-binding to the protein [65]. FAD-binding is required
for the correct folding of E3 [66], which, in turn, affects dimer
formation. The decrease of molecular size from 64 kDa (com-
puted from the amino acid sequence for 6-His-Pf aE3) to the
60–62 kDa observed during SDS–PAGE is consistent with the
loss of about 15–34 amino acids and it is possible that this negat-
ively affects Pf aE3 co-factor binding and dimerization and thus
may modify protein structure and catalytic activity. However, the
kinetic parameters of the recombinant protein were comparable
with those determined for E3 from other organisms suggesting
that only a small proportion of the recombinant protein is negat-
ively affected, which is in agreement with the finding that Pf aE3
is stable at high protein concentrations in vitro. Overall, the pro-
tein expression system used here facilitates the generation of mil-
ligram amounts of purified protein that is enzymatically active
and appears to be structurally stable, provided it is stored at high
concentrations (> 10 μM) and thus provides a suitable system to
generate sufficient protein for future drug-screening efforts.
The sedimentation coefficient determined by SV (s020,w of
6.2 +− 0.1 S) is comparable with that determined for the human
E3 dimer (5.9 S, [45]) suggesting that the overall solution con-
formation might be similar. However, human E3 has a molecular
mass of 106 kDa compared with the 128 kDa of Pf aE3, so it
would not be unexpected for the sedimentation coefficient to be a
little higher. The additional loops observed in the Pf aE3 model,
if real, would serve to somewhat offset the increase in sediment-
ation coefficient afforded by the additional mass. The dimeric
nature of Pf aE3 is confirmed by SE and by the SAXS data in
which the radius of gyration, maximum particle dimension and
DAM all are consistent with a dimer. The positioning of the
‘missing’ loops and N-terminal portions in the proposed model
remains undetermined – modelling against one SAXS dataset
is inconclusive. This limitation notwithstanding, the AUC and
SAXS data are all consistent with a dimeric structure for Pf aE3
and are not inconsistent with the augmented homology model.
In addition to the two extra loops, the high-resolution model
positions a two-stranded anti-parallel β motif in the space that, in
the structure of human E3 plus the SBD of E3BP (PDB ID: 2F5Z,
[33]), is occupied by the E3BP SBD. Pf aE3 does not interact with
E3BP SBD, but rather the SBD of Pf E2 since the parasite genome
does not encode an e3bp homologue. The presence of this ‘extra’
β motif implies that this interaction may be quite different from
that observed for human E3-E3BP, supporting the suitability of
Pf aE3 as a target for the development of intervention strategies.
To further assess Pf aE3 function, we generated Pfae3 null
mutants (3D7	ae3). Our study corroborates that the gene/protein
is not essential for intra-erythrocytic development in P. fal-
ciparum 3D7. The deletion of Pfae3 did not affect parasite growth
rates. However, upon careful scrutiny of the intra-erythrocytic de-
velopment of 3D7	ae3, we observed that the mutant organisms
unusually maintained their synchronicity over several growth
cycles, while this is not a feature of the wild-type 3D7 line (Fig-
ure 5). The causal relationship between this observation and the
deletion of Pfae3 is not clear. A recent study identified Pf aE3 to
be not only part of PDC but also to be associated with parasite
DNA, which possibly suggests a regulatory role for the protein in
gene expression, in addition to its function in PDC activity [67].
Another important finding was that the loss of PDC function upon
Pfae3 deletion resulted in an elevation of enzyme levels involved
in the generation of acetyl-CoA in the mitochondrion such as
BCDH-E2 and mE3. This suggests that the loss of PDC activity
may lead to an increased activity of TCA activity in order to com-
pensate for the loss acetyl-CoA provision, which is in agreement
with a recent report showing that mitochondrial acetyl-CoA is
generated by the branched chain α-keto acid dehydrogenase [68].
In order to test whether the lack of PDC activity impacts
on the parasites’ ability to defend themselves against oxidative
Figure 6 Relative expression levels of proteins involved in redox control
(A) Parasite lysates of 3D7 and 3D7	Pfae3 clone 21 were generated and 20 μg of protein per lane were separated on
SDS–PAGE (4–12 % gel), and probed with antibodies raised against a variety of P. falciparum proteins and simultaneously
with anti-P. falciparum actin antibody as a loading control. The secondary antibody used was an IR dye-conjugated antibody,
which allowed quantification of signals. The relative expression levels of all proteins were calculated in relation to the
actin loading control. The data represent means of three independent blots +− S.D. Antibody sources and dilutions used
are given in the Experimental Procedure. (B) Parasite lysates of 3D7 and 3D7	Pfae3 clones 16 and 34 were separated
on 4–12 % SDS–PAGE (4–12 % gel), and probed with antibodies raised against a variety of P. falciparum proteins with
anti-P. falciparum actin antibody as a loading control essentially as described in (A). The data represent means of three
independent blots +− S.D. Antibody sources and dilutions used are given in the Experimental Procedure.
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stress, we exposed three 3D7	ae3 clones to pro-oxidants that chal-
lenge their redox homoeostasis. Interestingly, the 3D7	ae3 clones
showed a differential response to the inhibitors, which suggests
that they adapt in different ways to the loss of Pf aE3 function.
This is also reflected in our finding that changes in protein levels
observed upon ae3 deletion have clonal specificity (Figure 6).
Clones 16 and 34 showed an increased susceptibility to the ox-
idative stressor paraquat and also (less pronounced) to BSO,
which was in agreement with their reduced amounts of 1-CysPx
and 2-CysPx, respectively. The susceptibility of clone 21 to these
stressors was only marginally reduced and accordingly, the levels
of the two antioxidant enzymes were elevated. These data suggest
that Pf aE3 may play a role in protecting P. falciparum against
oxidative or xenobiotic challenges [69], although the adaptive re-
sponses that the parasites mount show clonal differences and this
phenomenon requires further investigation to fully appreciate the
flexibility of Plasmodium in response to environmental changes.
Overall, the present study has corroborated that Pf aE3 is not
essential for P. falciparum survival during erythrocytic life, but
that the protein plays a role independent of apicoplast PDC in
maintaining cellular redox homoeostasis and that it impacts on
cell cycle progression during this life-cycle stage. These pheno-
types require further investigation to fully understand the func-
tions of the protein in addition to being a vital component of
apicoplast PDC. In addition, we provide evidence for a dimeric
Pf aE3 molecule in solution that differs significantly from its hu-
man counterpart, thus offering the potential for the development
of transmission-blocking or exo-erythrocytic anti-malarial inter-
vention strategies.
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